TY - JOUR
T1 - Data From a One-Stop-Shop Comprehensive Cancer Screening Center
AU - Bernstein, Ezra
AU - Lev-Ari, Shahar
AU - Shapira, Shiran
AU - Leshno, Ari
AU - Sommer, Udi
AU - Al-Shamsi, Humaid
AU - Shaked, Meital
AU - Segal, Ori
AU - Galazan, Lior
AU - Hay-Levy, Mori
AU - Sror, Miri
AU - Harlap-Gat, Amira
AU - Peer, Michael
AU - Moshkowitz, Menachem
AU - Wolf, Ido
AU - Liberman, Eliezer
AU - Shenberg, Gil
AU - Gur, Eyal
AU - Elran, Hanoch
AU - Melinger, Gustavo
AU - Mashiah, Jacob
AU - Isakov, Ofer
AU - Zrifin, Elad
AU - Gluck, Nathan
AU - Dekel, Roy
AU - Kleinman, Shlomi
AU - Aviram, Galit
AU - Blachar, Arye
AU - Kessler, Ada
AU - Golan, Orit
AU - Geva, Ravit
AU - Yossepowitch, Ofer
AU - Neugut, Alfred I.
AU - Arber, Nadir
N1 - Publisher Copyright:
© American Society of Clinical Oncology.
PY - 2023/5/10
Y1 - 2023/5/10
N2 - PURPOSECancer is the second leading cause of death globally. However, by implementing evidence-based prevention strategies, 30%-50% of cancers can be detected early with improved outcomes. At the integrated cancer prevention center (ICPC), we aimed to increase early detection by screening for multiple cancers during one visit.METHODSSelf-referred asymptomatic individuals, age 20-80 years, were included prospectively. Clinical, laboratory, and epidemiological data were obtained by multiple specialists, and further testing was obtained based on symptoms, family history, individual risk factors, and abnormalities identified during the visit. Follow-up recommendations and diagnoses were given as appropriate.RESULTSBetween January 1, 2006, and December 31, 2019, 8,618 men and 8,486 women, average age 47.11 ± 11.71 years, were screened. Of 259 cancers detected through the ICPC, 49 (19.8%) were stage 0, 113 (45.6%) stage I, 30 (12.1%) stage II, 25 (10.1%) stage III, and 31(12.5%) stage IV. Seventeen cancers were missed, six of which were within the scope of the ICPC. Compared with the Israeli registry, at the ICPC, less cancers were diagnosed at a metastatic stage for breast (none v 3.7%), lung (6.7% v 11.4%), colon (20.0% v 46.2%), prostate (5.6% v 10.5%), and cervical/uterine (none v 8.5%) cancers. When compared with the average stage of detection in the United States, detection was earlier for breast, lung, prostate, and female reproductive cancers. Patient satisfaction rate was 8.35 ± 1.85 (scale 1-10).CONCLUSIONWe present a proof of concept study for a one-stop-shop approach to cancer screening in a multidisciplinary outpatient clinic. We successfully detected cancers at an early stage, which has the potential to reduce morbidity and mortality as well as offer substantial cost savings.
AB - PURPOSECancer is the second leading cause of death globally. However, by implementing evidence-based prevention strategies, 30%-50% of cancers can be detected early with improved outcomes. At the integrated cancer prevention center (ICPC), we aimed to increase early detection by screening for multiple cancers during one visit.METHODSSelf-referred asymptomatic individuals, age 20-80 years, were included prospectively. Clinical, laboratory, and epidemiological data were obtained by multiple specialists, and further testing was obtained based on symptoms, family history, individual risk factors, and abnormalities identified during the visit. Follow-up recommendations and diagnoses were given as appropriate.RESULTSBetween January 1, 2006, and December 31, 2019, 8,618 men and 8,486 women, average age 47.11 ± 11.71 years, were screened. Of 259 cancers detected through the ICPC, 49 (19.8%) were stage 0, 113 (45.6%) stage I, 30 (12.1%) stage II, 25 (10.1%) stage III, and 31(12.5%) stage IV. Seventeen cancers were missed, six of which were within the scope of the ICPC. Compared with the Israeli registry, at the ICPC, less cancers were diagnosed at a metastatic stage for breast (none v 3.7%), lung (6.7% v 11.4%), colon (20.0% v 46.2%), prostate (5.6% v 10.5%), and cervical/uterine (none v 8.5%) cancers. When compared with the average stage of detection in the United States, detection was earlier for breast, lung, prostate, and female reproductive cancers. Patient satisfaction rate was 8.35 ± 1.85 (scale 1-10).CONCLUSIONWe present a proof of concept study for a one-stop-shop approach to cancer screening in a multidisciplinary outpatient clinic. We successfully detected cancers at an early stage, which has the potential to reduce morbidity and mortality as well as offer substantial cost savings.
UR - http://www.scopus.com/inward/record.url?scp=85159551816&partnerID=8YFLogxK
U2 - 10.1200/JCO.22.00938
DO - 10.1200/JCO.22.00938
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36669135
AN - SCOPUS:85159551816
SN - 0732-183X
VL - 41
SP - 2503
EP - 2510
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 14
ER -